322
Views
42
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

An epigenetic analysis of SOD1 and VEGF in ALS

&
Pages 83-86 | Received 13 Sep 2006, Accepted 01 Dec 2006, Published online: 10 Jul 2009

References

  • Andersen P. M. Genetics of sporadic ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2: S37–41
  • Lambrechts D., Storkebaum E., Morimoto M., Del‐Favero J., Desmet F., Marklund S. L., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motor neurons against ischaemic death. Nat Genet 2003; 54: 507–13
  • Robertson K. D. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597–610
  • Strachan T., Read A. P. Human Molecular Genetics. Bios, Oxford 2004
  • Yamada Y., Watanabe H., Miura F., Soejima H., Uchiyama M., Iwasaka T., et al. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. Genome Res 2004; 14: 247–66
  • Clark S. J., Harrison J., Paul C. L., Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990–7
  • Jan de Beur S., Ding C., Germain‐Lee E., Cho J., Maret A., Levine M. A. Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet 2003; 73: 314–22
  • Waterland R. A., Jirtle R. L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23: 5293–300
  • Richardson B. C. Role of DNA methylation in the regulation of cell function: autoimmunity, ageing and cancer. J Nutr 2002; 132: S2401–5
  • Ho Y. S., Gargano M., Cao J., Bronson R. T., Heimler I., Hutz R. J. Reduced fertility in female mice lacking copper‐zinc superoxide dismutase. J Biol Chem 1998; 273: 7765–9
  • Zheng C., Nennesmo I., Fadeel B., Henter J. I. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2004; 56: 564–7
  • Egger G., Liang G., Aparicio A., Jones P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429: 457–63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.